Pacific Wealth Strategies Group Inc. Has $2.53 Million Stock Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Pacific Wealth Strategies Group Inc. increased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 8.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 62,059 shares of the real estate investment trust’s stock after purchasing an additional 4,577 shares during the period. Omega Healthcare Investors makes up approximately 1.9% of Pacific Wealth Strategies Group Inc.’s investment portfolio, making the stock its 13th largest holding. Pacific Wealth Strategies Group Inc.’s holdings in Omega Healthcare Investors were worth $2,526,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. UMB Bank n.a. raised its holdings in Omega Healthcare Investors by 353.4% in the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 516 shares during the period. Versant Capital Management Inc acquired a new stake in Omega Healthcare Investors during the 2nd quarter worth $26,000. DiNuzzo Private Wealth Inc. bought a new position in Omega Healthcare Investors during the third quarter worth about $33,000. V Square Quantitative Management LLC grew its stake in Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after acquiring an additional 323 shares during the period. Finally, Covestor Ltd increased its holdings in shares of Omega Healthcare Investors by 47.6% in the first quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock worth $42,000 after acquiring an additional 431 shares in the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Trading Down 0.2 %

Shares of Omega Healthcare Investors stock opened at $42.43 on Friday. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. The business’s 50 day moving average is $40.42 and its 200-day moving average is $35.89. The stock has a market cap of $10.94 billion, a P/E ratio of 31.20, a P/E/G ratio of 1.37 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). The firm had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a return on equity of 9.19% and a net margin of 34.41%. The business’s revenue was up 17.5% compared to the same quarter last year. During the same period last year, the company posted $0.74 earnings per share. Equities research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be paid a $0.67 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.32%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 197.06%.

Insider Buying and Selling

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on OHI shares. Berenberg Bank assumed coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price target on the stock. Wells Fargo & Company restated an “overweight” rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Truist Financial upped their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price objective for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Finally, BMO Capital Markets boosted their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $39.70.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.